Table 1.
Association of MicroRNAs in Plasma and Circulating Microvesicles Categorized According to Median With Clinical Outcomes
| P Value (Chi‐Square Test) | ||
|---|---|---|
| Cardiovascular Mortality | MACE | |
| PmiR‐126 | 0.150 | 0.255 |
| PmiR‐222 | 0.364 | 0.555 |
| PmiR‐21 | 0.364 | 0.699 |
| PmiR‐20a | 0.364 | 0.477 |
| PmiR‐27a | 0.364 | 0.555 |
| PmiR‐92a | 0.364 | 0.699 |
| PmiR‐130 | 0.364 | 0.360 |
| PmiR‐let7d | 0.411 | 0.300 |
| PmiR‐199a | 0.741 | 0.360 |
| PmiR‐17 | 0.773 | 0.626 |
| MmiR‐222 | 0.741 | 0.215 |
| MmiR‐21 | 0.741 | 0.699 |
| MmiR‐20a | 0.138 | 0.360 |
| MmiR‐27a | 0.150 | 0.074 |
| MmiR‐92a | 0.364 | 0.059 |
| MmiR‐130 | 0.364 | 0.118 |
| MmiR‐let7d | 0.138 | 0.215 |
| MmiR‐17 | 0.387 | 0.416 |
MACE indicates major adverse cardiovascular event; MmiR, microRNA in circulating microvesicles; PmiR, microRNA in plasma.
*
Analysis were performed according to the median of microRNA level.